![Michael Smolinski](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Smolinski
Directeur Technique/Scientifique/R&D chez
VERADERMICS, INCORPORATED
Profil
Michael Smolinski is Vice President-Development & Scientific Operations at Veradermics, Inc. since 2023.
Formerly, Dr. Smolinski was Chief Scientific Officer at Athenex, Inc. from 2008 to 2022 and Chief Technology Officer at Homecare Homebase LLC.
Dr. Smolinski earned a doctorate from the State University of New York at Buffalo.
Postes actifs de Michael Smolinski
| Sociétés | Poste | Début |
|---|---|---|
| VERADERMICS, INCORPORATED | Directeur Technique/Scientifique/R&D | 01/07/2023 |
Anciens postes connus de Michael Smolinski
| Sociétés | Poste | Fin |
|---|---|---|
| ATHENEXPAR | Directeur Technique/Scientifique/R&D | 01/05/2022 |
Homecare Homebase LLC
 Homecare Homebase LLC Packaged SoftwareTechnology Services Develops software solutions for managing homecare and hospice agencies | Directeur Technique/Scientifique/R&D | - |
Formation de Michael Smolinski
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
52
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Athenex, Inc.
 Athenex, Inc. BiotechnologyHealth Technology Develops and commercializes drugs for cancer and immunomodulatory diseases | Health Technology |
State University of New York at Buffalo
 State University of New York at Buffalo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Homecare Homebase LLC
Homecare Homebase LLC Packaged SoftwareTechnology Services Develops software solutions for managing homecare and hospice agencies | Technology Services |
Veradermics, Inc.
 Veradermics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company for treatment of dermatology and aesthetics problems | Health Technology |
